OMM Treatment for Parkinson's Disease

Recruiting in Palo Alto (17 mi)

Overseen byTo Shan Li, D.O.

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: New York Institute of Technology

No Placebo Group

Trial Summary

What is the purpose of this trial?The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

Eligibility Criteria

This trial is for individuals over 40 with Parkinson's disease who also suffer from constipation as defined by the Rome III criteria. It aims to help those looking for non-drug treatments.

Inclusion Criteria

I have been diagnosed with Parkinson's disease.

I am over 40 years old.

I have been medically diagnosed with constipation.

Exclusion Criteria

I have been diagnosed with irritable bowel syndrome.

My cancer is located in my digestive system, abdomen, or pelvis.

I have a diagnosed reason for my long-term constipation.

+13 more

Participant Groups

The study tests Osteopathic Manipulative Medicine (OMM), a gentle manual treatment, to see if it reduces constipation in Parkinson's patients and possibly affects mouth and gut bacteria.

2Treatment groups

Experimental Treatment

Active Control

Group I: OMM treatmentExperimental Treatment1 Intervention

Subject will receive osteopathic manipulative treatment protocol for constipation in Parkinson's disease once a week for 4 weeks, in addition to continuing with their routine care

Group II: ControlActive Control1 Intervention

Subjects will continue with their routine care. No OMM will be performed during this study period